Reply to Richard J. Wassersug, Paul F. Schellhammer, and Erik Wibowo's Letter to the Editor re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3–7

Christopher J. Logothetis; Andrew W. Hahn

doi:10.1016/j.eururo.2024.03.019

Reply to Richard J. Wassersug, Paul F. Schellhammer, and Erik Wibowo's Letter to the Editor re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3–7

Christopher J. Logothetis, Andrew W. Hahn

Genitourinary Medical Oncology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	e175
Journal	European urology
Volume	85
Issue number	6
DOIs	https://doi.org/10.1016/j.eururo.2024.03.019
State	Published - Jun 2024

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2024.03.019

Cite this

Logothetis, C. J., & Hahn, A. W. (2024). Reply to Richard J. Wassersug, Paul F. Schellhammer, and Erik Wibowo's Letter to the Editor re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3–7. European urology, 85(6), e175. https://doi.org/10.1016/j.eururo.2024.03.019

Reply to Richard J. Wassersug, Paul F. Schellhammer, and Erik Wibowo's Letter to the Editor re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3–7. / Logothetis, Christopher J.; Hahn, Andrew W.
In: European urology, Vol. 85, No. 6, 06.2024, p. e175.

Research output: Contribution to journal › Letter › peer-review

Logothetis, CJ & Hahn, AW 2024, 'Reply to Richard J. Wassersug, Paul F. Schellhammer, and Erik Wibowo's Letter to the Editor re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3–7', European urology, vol. 85, no. 6, pp. e175. https://doi.org/10.1016/j.eururo.2024.03.019

@article{6ff04d87b8dc46058e121a59c295d5ab,

title = "Reply to Richard J. Wassersug, Paul F. Schellhammer, and Erik Wibowo's Letter to the Editor re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3–7",

author = "Logothetis, {Christopher J.} and Hahn, {Andrew W.}",

year = "2024",

month = jun,

doi = "10.1016/j.eururo.2024.03.019",

language = "English (US)",

volume = "85",

pages = "e175",

journal = "European urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

number = "6",

}

TY - JOUR

T1 - Reply to Richard J. Wassersug, Paul F. Schellhammer, and Erik Wibowo's Letter to the Editor re

T2 - Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3–7

AU - Logothetis, Christopher J.

AU - Hahn, Andrew W.

PY - 2024/6

Y1 - 2024/6

UR - http://www.scopus.com/inward/record.url?scp=85190531251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85190531251&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2024.03.019

DO - 10.1016/j.eururo.2024.03.019

M3 - Letter

C2 - 38538427

AN - SCOPUS:85190531251

SN - 0302-2838

VL - 85

SP - e175

JO - European urology

JF - European urology

IS - 6

ER -

Reply to Richard J. Wassersug, Paul F. Schellhammer, and Erik Wibowo's Letter to the Editor re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3–7

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this